Breaking News

ClearPoint Neuro (CLPT) announced a worldwide license and research agreement with Philips (PHG), to commercialize the ClearPoint 'Maestro' Brain Model. The company expects the first-generation anatomical segment analysis tool to be launched in 2022.

Koninklijke Philips N.V. (PHG) is acquiring Biotelemetry (BEAT) in a deal expected to be completed soon pending final conditions.

Garmin International, a unit of Garmin (GRMN), announced victory in a trade lawsuit brought by Philips North America and Koninklijke Philips (PHG) against Garmin. An Administrative Law Judge, or ALJ, at the International Trade Commission, or ITC, issued an initial determination on February 4, finding that Philips' asserted patents were invalid and did not cover Garmin's popular wearable devices. The initial determination is subject to review by the ITC.

Philips and the Dutch SAZ group of 28 hospitals have signed a strategic partnership agreement for a minimum of five years in the field of connected care. The partnership will encompass the monitoring, observation and self-management of patients throughout the entire care journey, both inside and outside the hospitals, supported by Philips advanced patient monitoring and population health management solutions. The company said, "During the course of 2021 about ten SAZ hospitals will start the collaboration focused either on hospital care or care in the community. In-hospital applications will include early detection of patient deterioration on nursing wards using Philips' IntelliVue Guardian Solution, which the Bravis hospital in Bergen op Zoom and Roosendaal, the Netherlands, already has experience of using. The Bravis hospital is also already using Philips' wearable biosensor and will use it to make a better connection between patient monitoring in the hospital's ICU and its nursing wards, reducing the length of stay in the ICU and helping to prevent ICU re-admissions. In addition, the solution will help a patient to return to a long term care setting or their own home. By creating an automatic link between the Philips biosensor, the Philips IntelliVue Guardian software and the hospital's EMR system, the organization aims to reduce the time nurses spend on administration. Other hospitals will start projects in the field of home monitoring and self-management for patients, something that IJsselland Hospital in Capelle aan den IJssel, the Netherlands, is already doing with Philips as part of a telemonitoring project for patients with heart failure and COPD. Patients measure their blood pressure and weight at home, and this data is monitored by heart failure nurses in the hospital. Patients also receive additional information and tips on how to manage their condition. The aim is to prevent readmissions and increase patient engagement, something that will be supported by Philips' patient-centric Engage platform, which provides patient and provider access to an overview of the patient's health information. The SAZ has experience with multiparty collaborations to improve healthcare. In 2017 the 28 hospitals started the company BeterDichtbij BV. BeterDichtbij is now used by 35 hospitals in the Netherlands. As part of the strategic collaboration between SAZ a connection will be realized between BeterDichtbij and the Philips Engage platform."

Koninklijke Philips N.V. (PHG) is acquiring Biotelemetry (BEAT) in a deal expected to be completed soon pending final conditions.

Philips introduced ClarifEye augmented reality surgical navigation, a solution to advance minimally-invasive spine procedures in the Hybrid Operating Room, such as Philips' Hybrid Suite. By combining 2D and 3D visualizations at low X-ray dose with 3D augmented reality, or AR, the solution provides live intra-operative visual feedback to support accurate placement of pedicle screws during spinal fusion procedures. During such procedures, two or more vertebrae in the spine are permanently connected to help improve stability, correct a deformity, or reduce pain. The solution is fully integrated into the Philips Azurion image-guided therapy platform, supporting workflow with intra-procedural navigation and verification for accurate screw placement and reducing the need for post-operative CT scans.

Royal Philips introduced the Philips Medical Tablet, an end-to-end portable monitoring kit designed to help clinicians remotely monitor larger patient populations during emergency situations, like the COVID-19 pandemic. The Medical Tablet integrates with Philips advanced IntelliVue XDS software to enable remote access of patient monitoring information. This solution can therefore be operated through WiFi connection.